Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 05, 2016 ) The report provides comprehensive information on the therapeutics under development for Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) and features dormant and discontinued projects.
Publisher's Leber Hereditary Optic Neuropathy Industry report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - The report reviews pipeline therapeutics for Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) therapeutics and enlists all their major and minor projects - The report assesses Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001231633/buying
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001231633/sample
Table of Content: An Overview
Introduction 6 Global Markets Direct Report Coverage 6 Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) Overview 7 Therapeutics Development 8 Pipeline Products for Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Overview 8 Pipeline Products for Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Comparative Analysis 9 Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Therapeutics under Development by Companies 10 Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Therapeutics under Investigation by Universities/Institutes 11 Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Products Glance 12 Late Stage Products 12 Clinical Stage Products 13 Early Stage Products 14 Unknown Stage Products 15 Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Products under Development by Companies 16 Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Products under Investigation by Universities/Institutes 17 Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Companies Involved in Therapeutics Development 18
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001231633/discount
Alkeus Pharmaceuticals, Inc. 18 Biovista Inc. 19 GenSight Biologics S.A. 20 Khondrion BV 21 Spark Therapeutics, Inc. 22 Stealth BioTherapeutics Inc. 23 Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Therapeutics Assessment 24 Assessment by Monotherapy Products 24 Assessment by Target 25 Assessment by Mechanism of Action 27 Assessment by Route of Administration 29 Assessment by Molecule Type 31 Drug Profiles 33 BVA-202 - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001231633/buy/2000
About ReportsWeb: ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|